M.D. Sass LLC’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107M Buy
1,286,942
+13,626
+1% +$1.04M 7.02% 1
2026
Q1
$93.8M Buy
1,273,316
+35,443
+3% +$2.74M 7.11% 1
2025
Q4
$93.6M Sell
1,237,873
-76,730
-6% -$5.4M 7.37% 1
2025
Q3
$87.3M Buy
1,314,603
+230,407
+21% +$15.9M 7.11% 1
2025
Q2
$79.2M Buy
+1,084,196
New +$74.6M 6.38% 2

Other funds holding HSIC

M.D. Sass LLC's HSIC Position: Q2 2026 in Review

M.D. Sass LLC increased its Henry Schein (HSIC) stake by 1.1% in Q2 2026, buying an estimated $1.04M and bringing the position to 1,286,942 shares worth $107M. The position accounts for 7.02% of the portfolio, ranked #1.

M.D. Sass LLC first reported a position in HSIC in Q2 2025 and has held it in 5 quarters since. 564 funds tracked by Wall St. Rank hold HSIC as of Q2 2026.

  • M.D. Sass LLC held 1,286,942 shares of Henry Schein worth $107M as of Q2 2026.
  • M.D. Sass LLC bought 13,626 Henry Schein shares in Q2 2026, an estimated $1.04M.
  • Henry Schein made up 7.02% of M.D. Sass LLC's portfolio in Q2 2026, its #1 holding.
  • M.D. Sass LLC first reported a position in Henry Schein in Q2 2025 and has held it in 5 quarters since.
  • 564 funds tracked by Wall St. Rank held Henry Schein as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.